Skip to main content
Caplight Logo









Formulary Financial

Formulary Financial

Private
New York City, New YorkFinTechhttps://www.formulary.co/

Last Round

Seed

Jan 20, 2026

Total Funding Raised

$8.82M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Formulary Financial is a financial software company that provides an AI-native fund administration platform to support asset managers with data management, accounting, and operational workflows.

Sector

FinTech

Verticals

Accounting & Expense, Wealth Management, Compliance & Risk, Workflow Automation

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

fund administrationfund accountingprivate equity softwareAI-native accountingautomated reportingFinOpsventure capital operationsalternative asset managementback-office automationLP portalfund admin techregulatory compliancetreasury servicesaudit preparationCFO advisory

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Formulary Financial Comparables

Compare Formulary Financial with similar companies based on industry and business-model similarity.

Formulary Financial comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hanover Park
88%
Zive AI
87%
Caruso
84%

Formulary Financial Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 20, 2026
SeedApr 30, 2025

Formulary Financial Investors

Notable investors and investment history

Formulary Financial investors
InvestorRounds
Human VenturesSeed
Company VenturesSeed
Khosla VenturesSeed
Company VenturesSeed
Acrew CapitalSeed
Serena VenturesSeed
Alumni VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    $4.6M raised in Seed round.

Formulary Financial Filings

Explore SEC and related filing metadata, where available.

Formulary Financial filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Formulary Financial's valuation, stock price, and market status.

Is Formulary Financial a public or private company?

Formulary Financial is a private company.

What is the current stock price of Formulary Financial?

Formulary Financial is a private company with no public stock price. No recent secondary market data is available.

How much is Formulary Financial worth (valuation)?

Valuation information for Formulary Financial is not publicly available.

Can I buy Formulary Financial stock?

Formulary Financial shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Formulary Financial's last funding round?

Formulary Financial's most recent funding round was Seed on January 20, 2026.

Who are the main investors in Formulary Financial?

Key investors in Formulary Financial include Khosla Ventures.

Will Formulary Financial IPO soon?

No public IPO plans have been announced for Formulary Financial.

How can I track Formulary Financial secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Formulary Financial's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Year Founded2025
Last FundingJan 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?